AIDX
NASD 20/20 Biolabs, Inc.$0.2603 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.2603, $0.0396 below the day’s high of $0.2999
- YTD change
- -98.91%
- vs 20-day SMA
- -31.83%
- vs 200-day SMA
- N/A
Price ranges
Price & Performance
-1.45 (-84.78%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.5% away from all-time highs of $50.0000
- AIDX is down 99% since the beginning of the year
- AIDX is down 99% over the past 12 months
- AIDX is down 44% over the past 1 month
- 0% of all AIDX investors are betting against AIDX
AIDX reads poor: the 12-month move is -98.9%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0000
- Last 5 days
- -30.59%
- vs 8-day SMA
- -21.82%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was founded by Jonathan Cohen in May 2000 and is headquartered in Gaithersburg, MD.
Competitor comparison
No peer group available for this symbol.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.